Implementation Guidelines - Federal Transit Administration - U.S. ...
Implementation Guidelines - Federal Transit Administration - U.S. ... Implementation Guidelines - Federal Transit Administration - U.S. ...
Page 25 of 100 (v) Invalid result, with remark(s). Laboratories will report actual values for pH results. (3) Category 3: Rejected for Testing. As a laboratory, when you reject a specimen for testing, you must report the result as being Rejected for Testing, with remark(s). (b) As a laboratory, you must report laboratory results directly, and only, to the MRO at his or her place of business. You must not report results to or through the DER or a service agent (e.g., C/TPA). (1) Negative results: You must fax, courier, mail, or electronically transmit a legible image or copy of the fully-completed Copy 1 of the CCF which has been signed by the certifying scientist, or you may provide the laboratory results report electronically (i.e., computer data file). (i) If you elect to provide the laboratory results report, you must include the following elements, as a minimum, in the report format: (A) Laboratory name and address; (B) Employer's name (you may include I.D. or account number); (C) Medical review officer's name; (D) Specimen I.D. number; (E) Donor's SSN or employee I.D. number, if provided; (F) Reason for test, if provided; (G) Collector's name and telephone number; (H) Date of the collection; (I) Date received at the laboratory; (J) Date certifying scientist released the results; (K) Certifying scientist's name; (L) Results (e.g., positive, adulterated) as listed in paragraph (a) of this section; and (M) Remarks section, with an explanation of any situation in which a correctable flaw has been corrected. (ii) You may release the laboratory results report only after review and approval by the certifying scientist. It must reflect the same test result information as contained on the CCF signed by the certifying scientist. The information contained in the laboratory results report may not contain information that does not appear on the CCF. (iii) The results report may be transmitted through any means that ensures accuracy and confidentiality. You, as the laboratory, together with the MRO, must ensure that the information is adequately protected from unauthorized access or release, both during transmission and in storage. (2) Non-negative and Rejected for Testing results: You must fax, courier, mail, or electronically transmit a legible image or copy of the fully-completed Copy 1 of the CCF that has been signed by the certifying scientist. In addition, you may provide the electronic laboratory results report following the format and procedures set forth in paragraphs (b)(1)(i) and (ii) of this section. (c) In transmitting laboratory results to the MRO, you, as the laboratory, together with the MRO, must ensure that the information is adequately protected from unauthorized access or release, both during transmission and in storage. If the results are provided by fax, the fax connection must have a fixed telephone number accessible only to authorized individuals. (d) You must transmit test results to the MRO in a timely manner, preferably the same day that review by the certifying scientist is completed. (e)(1) You must provide quantitative values for confirmed positive drug test results to the MRO when the MRO requests you to do so in writing. The MRO's request may be either a general request covering all such results you send to the MRO or a specific case-by-case request. (2) You must provide numerical values that support the adulterated (when applicable) or substituted result, without a request from the MRO. (3) You must also provide the MRO numerical values for creatinine and specific gravity for the negativedilute test result, without a request from the MRO. (f) You must provide quantitative values for confirmed opiate results for morphine or codeine at 15,000 ng/mL or above, even if the MRO has not requested quantitative values for the test result. [65 FR 79526, Dec. 19, 2000, as amended at 66 FR 41951, Aug. 9, 2001; 68 FR 31626, May 28, 2003; 69 FR 64867, Nov.9, 2004; 73 FR 35970, June 25, 2008] § 40.99 How long does the laboratory retain specimens after testing? (a) As a laboratory testing the primary specimen, you must retain a specimen that was reported with positive, adulterated, substituted, or invalid results for a minimum of one year. (b) You must keep such a specimen in secure, long-term, frozen storage in accordance with HHS requirements. (c) Within the one-year period, the MRO, the employee, the employer, or a DOT agency may request in writing that you retain a specimen for an additional period of time (e.g., for the purpose of preserving evidence for litigation or a safety investigation). If you receive such a request, you must comply with it. If you do not receive such a request, you may discard the specimen at the end of the year.
Page 26 of 100 (d) If you have not sent the split specimen to another laboratory for testing, you must retain the split specimen for an employee's test for the same period of time that you retain the primary specimen and under the same storage conditions. (e) As the laboratory testing the split specimen, you must meet the requirements of paragraphs (a) through (d) of this section with respect to the split specimen. § 40.101 What relationship may a laboratory have with an MRO? (a) As a laboratory, you may not enter into any relationship with an MRO that creates a conflict of interest or the appearance of a conflict of interest with the MRO's responsibilities for the employer. You may not derive any financial benefit by having an employer use a specific MRO. (b) The following are examples of relationships between laboratories and MROs that the Department regards as creating conflicts of interest, or the appearance of such conflicts. This following list of examples is not intended to be exclusive or exhaustive: (1) The laboratory employs an MRO who reviews test results produced by the laboratory; (2) The laboratory has a contract or retainer with the MRO for the review of test results produced by the laboratory; (3) The laboratory designates which MRO the employer is to use, gives the employer a slate of MROs from which to choose, or recommends certain MROs; (4) The laboratory gives the employer a discount or other incentive to use a particular MRO; (5) The laboratory has its place of business co-located with that of an MRO or MRO staff who review test results produced by the laboratory; or (6) The laboratory permits an MRO, or an MRO's organization, to have a financial interest in the laboratory. § 40.103 What are the requirements for submitting blind specimens to a laboratory? (a) As an employer or C/TPA with an aggregate of 2000 or more DOT-covered employees, you must send blind specimens to laboratories you use. If you have an aggregate of fewer than 2000 DOT-covered employees, you are not required to provide blind specimens. (b) To each laboratory to which you send at least 100 specimens in a year, you must transmit a number of blind specimens equivalent to one percent of the specimens you send to that laboratory, up to a maximum of 50 blind specimens in each quarter (i.e., January–March, April–June, July–September, October–December). As a C/TPA, you must apply this percentage to the total number of DOT-covered employees' specimens you send to the laboratory. Your blind specimen submissions must be evenly spread throughout the year. The following examples illustrate how this requirement works: Example 1 to Paragraph (b). You send 2500 specimens to Lab X in Year 1. In this case, you would send 25 blind specimens to Lab X in Year 1. To meet the even distribution requirement, you would send 6 in each of three quarters and 7 in the other. Example 2 to Paragraph (b). You send 2000 specimens to Lab X and 1000 specimens to Lab Y in Year 1. In this case, you would send 20 blind specimens to Lab X and 10 to Lab Y in Year 1. The even distribution requirement would apply in a similar way to that described in Example 1. Example 3 to Paragraph (b). Same as Example 2, except that you also send 20 specimens to Lab Z. In this case, you would send blind specimens to Labs X and Y as in Example 2. You would not have to send any blind specimens to Lab Z, because you sent fewer than 100 specimens to Lab Z. Example 4 to Paragraph (b). You are a C/TPA sending 2000 specimens to Lab X in Year 1. These 2000 specimens represent 200 small employers who have an average of 10 covered employees each. In this case you—not the individual employers—send 20 blind specimens to Lab X in Year 1, again ensuring even distribution. The individual employers you represent are not required to provide any blind specimens on their own. Example 5 to Paragraph (b). You are a large C/TPA that sends 40,000 specimens to Lab Y in Year 1. One percent of that figure is 400. However, the 50 blind specimen per quarter “cap” means that you need send only 50 blind specimens per quarter, rather than the 100 per quarter you would have to send to meet the one percent rate. Your annual total would be 200, rather than 400, blind specimens. (c) Approximately 75 percent of the specimens you submit must be negative (i.e., containing no drugs, nor adulterated or substituted). Approximately 15 percent must be positive for one or more of the five drugs involved in DOT tests, and approximately 10 percent must either be adulterated with a substance cited in HHS guidance or substituted (i.e., having specific gravity and creatinine meeting the criteria of §40.93(b)). (1) All negative, positive, adulterated, and substituted blind specimens you submit must be certified by the supplier and must have supplier-provided expiration dates. (2) Negative specimens must be certified by immunoassay and GC/MS to contain no drugs. (3) Drug positive blind specimens must be certified by immunoassay and GC/MS to contain a drug(s)/ metabolite(s) between 1.5 and 2 times the initial drug test cutoff concentration.
- Page 348 and 349: actual employee of the employer may
- Page 350 and 351: Q: Must collectors, BATs, STTs, MRO
- Page 352 and 353: an observer, or a monitor for co-wo
- Page 354 and 355: Q: If a collector makes an error on
- Page 356 and 357: Appendix H Terms and Definitions
- Page 358 and 359: indirectly, one controls or has the
- Page 360 and 361: Confirmation validity test Confirme
- Page 362 and 363: These terms include any designee of
- Page 364 and 365: Medical Review Officer (MRO) A pers
- Page 366 and 367: Random test Reason to believe Reaso
- Page 368 and 369: Safety-sensitive function Any of th
- Page 370 and 371: trolley bus, or vessel. A “mass t
- Page 373 and 374: 49 CFR Part 40 Updated August 31, 2
- Page 375 and 376: § 40.89 What is validity testing,
- Page 377 and 378: Page 4 of 100 § 40.287 What inform
- Page 379 and 380: Page 6 of 100 Subpart A - Administr
- Page 381 and 382: Page 8 of 100 Medical Review Office
- Page 383 and 384: Page 10 of 100 § 40.17 Is an emplo
- Page 385 and 386: Page 12 of 100 (b) You must request
- Page 387 and 388: Page 14 of 100 (4) The collector's
- Page 389 and 390: Page 16 of 100 (1) To avoid distrac
- Page 391 and 392: Page 18 of 100 (f) Direct the emplo
- Page 393 and 394: Page 20 of 100 (g) As the collector
- Page 395 and 396: Page 22 of 100 participate in the D
- Page 397: Page 24 of 100 (b) You must determi
- Page 401 and 402: Page 28 of 100 December 31 of the p
- Page 403 and 404: Page 30 of 100 (a) Review Copy 2 of
- Page 405 and 406: Page 32 of 100 (1) As the DER, you
- Page 407 and 408: Page 34 of 100 (i) Recent needle tr
- Page 409 and 410: Page 36 of 100 (2) If you receive i
- Page 411 and 412: Page 38 of 100 (iii) If a negative
- Page 413 and 414: Page 40 of 100 (6) Result of the te
- Page 415 and 416: Page 42 of 100 (d) When you receive
- Page 417 and 418: Page 44 of 100 (1) Report that the
- Page 419 and 420: Page 46 of 100 (2) There is not an
- Page 421 and 422: Page 48 of 100 (c) The laboratory r
- Page 423 and 424: Page 50 of 100 (6) The failure to d
- Page 425 and 426: Page 52 of 100 partially meets thes
- Page 427 and 428: Page 54 of 100 (c) As the user of t
- Page 429 and 430: Page 56 of 100 (vi) You must then d
- Page 431 and 432: Page 58 of 100 (i) You may transmit
- Page 433 and 434: Page 60 of 100 (b) In the case of a
- Page 435 and 436: Page 62 of 100 (iii) Key DOT drug t
- Page 437 and 438: Page 64 of 100 § 40.295 May employ
- Page 439 and 440: Page 66 of 100 (e) The requirements
- Page 441 and 442: Page 68 of 100 accident drug test r
- Page 443 and 444: Page 70 of 100 § 40.343 What tasks
- Page 445 and 446: Page 72 of 100 and follow-up testin
- Page 447 and 448: Page 74 of 100 (b) In exercising th
Page 25 of 100<br />
(v) Invalid result, with remark(s). Laboratories will report actual values for pH results.<br />
(3) Category 3: Rejected for Testing. As a laboratory, when you reject a specimen for testing, you must<br />
report the result as being Rejected for Testing, with remark(s).<br />
(b) As a laboratory, you must report laboratory results directly, and only, to the MRO at his or her place of<br />
business. You must not report results to or through the DER or a service agent (e.g., C/TPA).<br />
(1) Negative results: You must fax, courier, mail, or electronically transmit a legible image or copy of the<br />
fully-completed Copy 1 of the CCF which has been signed by the certifying scientist, or you may provide the<br />
laboratory results report electronically (i.e., computer data file).<br />
(i) If you elect to provide the laboratory results report, you must include the following elements, as a<br />
minimum, in the report format:<br />
(A) Laboratory name and address;<br />
(B) Employer's name (you may include I.D. or account number);<br />
(C) Medical review officer's name;<br />
(D) Specimen I.D. number;<br />
(E) Donor's SSN or employee I.D. number, if provided;<br />
(F) Reason for test, if provided;<br />
(G) Collector's name and telephone number;<br />
(H) Date of the collection;<br />
(I) Date received at the laboratory;<br />
(J) Date certifying scientist released the results;<br />
(K) Certifying scientist's name;<br />
(L) Results (e.g., positive, adulterated) as listed in paragraph (a) of this section; and<br />
(M) Remarks section, with an explanation of any situation in which a correctable flaw has been corrected.<br />
(ii) You may release the laboratory results report only after review and approval by the certifying scientist.<br />
It must reflect the same test result information as contained on the CCF signed by the certifying scientist. The<br />
information contained in the laboratory results report may not contain information that does not appear on the CCF.<br />
(iii) The results report may be transmitted through any means that ensures accuracy and confidentiality.<br />
You, as the laboratory, together with the MRO, must ensure that the information is adequately protected from<br />
unauthorized access or release, both during transmission and in storage.<br />
(2) Non-negative and Rejected for Testing results: You must fax, courier, mail, or electronically transmit a<br />
legible image or copy of the fully-completed Copy 1 of the CCF that has been signed by the certifying scientist. In<br />
addition, you may provide the electronic laboratory results report following the format and procedures set forth in<br />
paragraphs (b)(1)(i) and (ii) of this section.<br />
(c) In transmitting laboratory results to the MRO, you, as the laboratory, together with the MRO, must<br />
ensure that the information is adequately protected from unauthorized access or release, both during transmission<br />
and in storage. If the results are provided by fax, the fax connection must have a fixed telephone number accessible<br />
only to authorized individuals.<br />
(d) You must transmit test results to the MRO in a timely manner, preferably the same day that review by<br />
the certifying scientist is completed.<br />
(e)(1) You must provide quantitative values for confirmed positive drug test results to the MRO when the<br />
MRO requests you to do so in writing. The MRO's request may be either a general request covering all such results<br />
you send to the MRO or a specific case-by-case request.<br />
(2) You must provide numerical values that support the adulterated (when applicable) or substituted result,<br />
without a request from the MRO.<br />
(3) You must also provide the MRO numerical values for creatinine and specific gravity for the negativedilute<br />
test result, without a request from the MRO.<br />
(f) You must provide quantitative values for confirmed opiate results for morphine or codeine at 15,000<br />
ng/mL or above, even if the MRO has not requested quantitative values for the test result.<br />
[65 FR 79526, Dec. 19, 2000, as amended at 66 FR 41951, Aug. 9, 2001; 68 FR 31626, May 28, 2003; 69 FR<br />
64867, Nov.9, 2004; 73 FR 35970, June 25, 2008]<br />
§ 40.99 How long does the laboratory retain specimens after testing?<br />
(a) As a laboratory testing the primary specimen, you must retain a specimen that was reported with<br />
positive, adulterated, substituted, or invalid results for a minimum of one year.<br />
(b) You must keep such a specimen in secure, long-term, frozen storage in accordance with HHS<br />
requirements.<br />
(c) Within the one-year period, the MRO, the employee, the employer, or a DOT agency may request in<br />
writing that you retain a specimen for an additional period of time (e.g., for the purpose of preserving evidence for<br />
litigation or a safety investigation). If you receive such a request, you must comply with it. If you do not receive<br />
such a request, you may discard the specimen at the end of the year.